EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us

ABPI welcomes the UK Chancellor’s new Budget

The Association of the British Pharmaceutical Industry has expressed support for the first Labour budget in 14 years.
Vaccines on blue background

CDC panel backs expanded use of pneumococcal vaccines in adults

Pfizer and Merck’s pneumococcal vaccines have been recommended for adults aged 50 and over in the US, potentially opening up a new market.
Handshake on a green background

Merck acquires Modifi Biosciences in $1.3bn cancer therapy deal

The acquisition strengthens Merck’s oncology portfolio as the company looks to off the expiration of the patent for pembrolizumab.
Gold crown on blue background

HCPs rank pharma in top sectors for trust, says Ipsos

Healthcare professionals’ trust in the pharmaceutical industry has risen since 2020, with many doctors and nurses now expressing high trust.
sad woman crouching with a helping hand

Boehringer pledges $5m to WHO Foundation mental health initiative

Discover how this partnership could enhance access to quality healthcare, with an emphasis on mental health services for vulnerable populations in the Americas.
Cartoon of London houses of parliament

Britain explores Eli Lilly’s obesity drug to tackle long-term sickness

The British government is set to explore whether Eli Lilly’s weight-loss drug could play a pivotal role in getting people back to work.
Handshake on blue background

Lundbeck to acquire Longboard and potential blockbuster epilepsy drug

Lundbeck will acquire Longboard Pharmaceuticals, aiming to strengthen its portfolio with its potential blockbuster epilepsy treatment.
contract

Thomas J. Fuchs appointed as Lilly's first Chief AI Officer

Eli Lilly and Company appoints their first Chief AI Officer in Thomas J. Fuchs, to spearhead the strategic direction and leadership of AI.